Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-038366
Filing Date
2007-02-23
Accepted
2007-02-23 16:18:12
Documents
10
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1256310
2 AMENDMENT NO. 4 TO RIGHTS AGREEMENT dex410.htm EX-4.10 8027
3 SUBSIDIARIES dex211.htm EX-21.1 1804
4 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1775
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8986
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 4268
7 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 8991
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4300
9 GRAPHIC g20718g42x57.jpg GRAPHIC 22615
10 GRAPHIC g20718g68a85.jpg GRAPHIC 53167
  Complete submission text file 0001193125-07-038366.txt   1400553
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

EIN.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27756 | Film No.: 07645948
SIC: 2834 Pharmaceutical Preparations